NCT07840326: A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- State
- Under way
- Phase
- Phase 2
- People
- 20 planned
- Started
- Oct 2026
- Primary completion
- Jun 2027
- Arms
- SUN-627 Dose Level 1, SUN-627 Dose Level 2
- Results
- None posted
- 25 Sep 2026: Trial registered